123 related articles for article (PubMed ID: 1348177)
1. Enzymuria in neonates receiving continuous intravenous infusion of gentamicin.
Colding H; Brygge K; Brendstrup L; Bentzon MW; Andersen GE
APMIS; 1992 Feb; 100(2):119-24. PubMed ID: 1348177
[TBL] [Abstract][Full Text] [Related]
2. [Enzymuria and kidney diseases in childhood].
Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B
Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics.
Nix DE; Thomas JK; Symonds WT; Spivey JM; Wilton JH; Gagliardi NC; Schentag JJ
Ann Pharmacother; 1997 Jun; 31(6):696-703. PubMed ID: 9184707
[TBL] [Abstract][Full Text] [Related]
4. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin.
Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC
Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP)].
Bertotti A; De Marchi S; Brovedani P; Gaeta G; Peratoner L; Mangiarotti MA
Pediatr Med Chir; 1990; 12(4):347-9. PubMed ID: 1981610
[TBL] [Abstract][Full Text] [Related]
7. Enzymuria in neonates during treatment with gentamicin or tobramycin.
Tessin I; Trollfors B; Bergmark J; Jagenburg R; Hultberg B
Pediatr Infect Dis J; 1987 Sep; 6(9):870-1. PubMed ID: 2890136
[No Abstract] [Full Text] [Related]
8. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers.
Chapelsky MC; Nix DE; Cavanaugh JC; Wilton JH; Norman A; Schentag JJ
Drug Saf; 1992; 7(4):304-9. PubMed ID: 1355971
[TBL] [Abstract][Full Text] [Related]
10. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity.
Whiting PH; Brown PA
Ren Fail; 1996 Nov; 18(6):899-909. PubMed ID: 8948524
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside-related nephrotoxicity in the premature newborn.
Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
[TBL] [Abstract][Full Text] [Related]
12. The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteers.
Kazierad DJ; Wojcik GJ; Nix DE; Goldfarb AL; Schentag JJ
J Clin Pharmacol; 1995 Feb; 35(2):196-201. PubMed ID: 7751432
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats.
Fauconneau B; Favrelière S; Pariat C; Génévrier A; Courtois P; Piriou A; Bouquet S
Ren Fail; 1997 Jan; 19(1):15-22. PubMed ID: 9044448
[TBL] [Abstract][Full Text] [Related]
14. Renal toxicity of aminoglycosides in the neonatal period.
Heimann G
Pediatr Pharmacol (New York); 1983; 3(3-4):251-7. PubMed ID: 6146123
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal tubular effects in relation to urine cadmium levels.
Mueller PW; Smith SJ; Steinberg KK; Thun MJ
Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of three specific renal tubular enzymes in patients treated with nonsteroidal anti-inflammatory drugs (NSAID).
Zafirovska KG; Bogdanovska SV; Marina N; Gruev T; Lozance L
Ren Fail; 1993; 15(1):51-4. PubMed ID: 8095099
[TBL] [Abstract][Full Text] [Related]
17. Estimation of quantitative enzymuria in dogs with gentamicin-induced nephrotoxicosis using urine enzyme/creatinine ratios from spot urine samples.
Grauer GF; Greco DS; Behrend EN; Mani I; Fettman MJ; Allen TA
J Vet Intern Med; 1995; 9(5):324-7. PubMed ID: 8531177
[TBL] [Abstract][Full Text] [Related]
18. Study of alanine aminopeptidase excretion as a test of gentamicin nephrotoxicity.
Davey PG; Geddes AM; Cowley DM
J Antimicrob Chemother; 1983 May; 11(5):455-65. PubMed ID: 6135686
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
Donta ST; Lembke LA
Antimicrob Agents Chemother; 1985 Oct; 28(4):500-3. PubMed ID: 4073872
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants.
Giacoia GP; Schentag JJ
J Pediatr; 1986 Oct; 109(4):715-9. PubMed ID: 3531452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
